<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38495122</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2688-2663</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>MedComm</Title><ISOAbbreviation>MedComm (2020)</ISOAbbreviation></Journal><ArticleTitle>Alterations in microbiota of patients with COVID-19: implications for therapeutic interventions.</ArticleTitle><Pagination><StartPage>e513</StartPage><MedlinePgn>e513</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e513</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/mco2.513</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently caused a global pandemic, resulting in more than 702 million people being infected and over 6.9 million deaths. Patients with coronavirus disease (COVID-19) may suffer from diarrhea, sleep disorders, depression, and even cognitive impairment, which is associated with long COVID during recovery. However, there remains no consensus on effective treatment methods. Studies have found that patients with COVID-19 have alterations in microbiota and their metabolites, particularly in the gut, which may be involved in the regulation of immune responses. Consumption of probiotics may alleviate the discomfort caused by inflammation and oxidative stress. However, the pathophysiological process underlying the alleviation of COVID-19-related symptoms and complications by targeting the microbiota remains unclear. In the current study, we summarize the latest research and evidence on the COVID-19 pandemic, together with symptoms of SARS-CoV-2 and vaccine use, with a focus on the relationship between microbiota alterations and COVID-19-related symptoms and vaccine use. This work provides evidence that probiotic-based interventions may improve COVID-19 symptoms by regulating gut microbiota and systemic immunity. Probiotics may also be used as adjuvants to improve vaccine efficacy.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. MedComm published by Sichuan International Medical Exchange &amp; Promotion Association (SCIMEA) and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology National Clinical Research Center for Geriatrics and The Research Units of West China (2018RU012) West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Anesthesia and Critical Care Medicine National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Chunheng</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2781-2132</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE State Key Laboratory of Biotherapy West China Second University Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology National Clinical Research Center for Geriatrics and The Research Units of West China (2018RU012) West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Anesthesia and Critical Care Medicine National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Wanlin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology National Clinical Research Center for Geriatrics and The Research Units of West China (2018RU012) West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Anesthesia and Critical Care Medicine National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology National Clinical Research Center for Geriatrics and The Research Units of West China (2018RU012) West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Anesthesia and Critical Care Medicine National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology National Clinical Research Center for Geriatrics and The Research Units of West China (2018RU012) West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Anesthesia and Critical Care Medicine National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology West China Hospital Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>MedComm (2020)</MedlineTA><NlmUniqueID>101769925</NlmUniqueID><ISSNLinking>2688-2663</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">probiotics</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>All authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>4</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38495122</ArticleId><ArticleId IdType="pmc">PMC10943180</ArticleId><ArticleId IdType="doi">10.1002/mco2.513</ArticleId><ArticleId IdType="pii">MCO2513</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Worldometers.info
. COVID&#x2010;19 Coronavirus Pandemic. Published February 6, 2024. Accessed February 6, 2024. https://www.worldometers.info/coronavirus/
</Citation></Reference><Reference><Citation>Bowe B, Xie Y, Al&#x2010;Aly Z. Postacute sequelae of COVID&#x2010;19 at 2 years. Nat Med. 2023;29(9):2347&#x2010;2357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et&#xa0;al. Development of a definition of postacute sequelae of SARS&#x2010;CoV&#x2010;2 infection. JAMA. 2023;329(22):1934&#x2010;1946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselingh R. Prevalence, pathogenesis and spectrum of neurological symptoms in COVID&#x2010;19 and post&#x2010;COVID&#x2010;19 syndrome: a narrative review. Med J Aust. 2023;219(5):230&#x2010;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">37660309</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee YJ, Fan BE, Young BE, Dalan R, Lye DC. Clinical trials on the pharmacological treatment of long COVID: a systematic review. J Med Virol. 2023;95(1):e28289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878018</ArticleId><ArticleId IdType="pubmed">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui G, Guaraldi G. Drug treatment of COVID&#x2010;19 infection. Curr Opin Pulm Med. 2023;29(3):174&#x2010;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10090306</ArticleId><ArticleId IdType="pubmed">36917228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA. 2023;329(13):1098&#x2010;1113.</Citation><ArticleIdList><ArticleId IdType="pubmed">37014337</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, et&#xa0;al. Post&#x2010;acute COVID&#x2010;19 syndrome (PCS) and health&#x2010;related quality of life (HRQoL)&#x2010;A systematic review and meta&#x2010;analysis. J Med Virol. 2022;94(1):253&#x2010;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak J, Su Q, et&#xa0;al. Gut microbiota dynamics in a prospective cohort of patients with post&#x2010;acute COVID&#x2010;19 syndrome. Gut. 2022;71(3):544&#x2010;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui G, et&#xa0;al. Alterations in gut microbiota of patients with COVID&#x2010;19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2010;955. e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, et&#xa0;al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID&#x2010;19. Gut. 2021;70(4):698&#x2010;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong KL, Chen S, Teng B, Veeraperumal S, Zhong S, Tan K. Oligosaccharides as potential regulators of gut microbiota and intestinal health in post&#x2010;COVID&#x2010;19 management. Pharmaceuticals (Basel). 2023;16(6):860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10301634</ArticleId><ArticleId IdType="pubmed">37375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov PV, Ghafari M, Beer M, et&#xa0;al. The evolution of SARS&#x2010;CoV&#x2010;2. Nat Rev Microbiol. 2023;21(6):361&#x2010;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodsi IA, Rayes DE, Koweyes J, et&#xa0;al. Tracking SARS&#x2010;CoV&#x2010;2 variants during the 2023 flu season and beyond in Lebanon. Virus Res. 2024;339:199289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10704499</ArticleId><ArticleId IdType="pubmed">38036064</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Deng X, Zhang L, et&#xa0;al. Single&#x2010;cell RNA sequencing analysis of lung cells in COVID&#x2010;19 patients with diabetes, hypertension, and comorbid diabetes&#x2010;hypertension. Front Endocrinol (Lausanne). 2023;14:1258646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10748394</ArticleId><ArticleId IdType="pubmed">38144556</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei S, Zou Y, Jiang S, et&#xa0;al. Highly potent dual&#x2010;targeting angiotensin&#x2010;converting enzyme 2 (ACE2) and Neuropilin&#x2010;1 (NRP1) peptides: a promising broad&#x2010;spectrum therapeutic strategy against SARS&#x2010;CoV&#x2010;2 infection. Eur J Med Chem. 2024;263:115908.</Citation><ArticleIdList><ArticleId IdType="pubmed">37981444</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton MJ, Gaggar A, Might M, Erdmann N, Orihuela CJ, Harrod KS. Community&#x2010;acquired bacterial coinfections and COVID&#x2010;19. Physiol Rev. 2024;104(1):1&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">37589392</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S, Cao T, Shen H, et&#xa0;al. Landscape of molecular crosstalk between SARS&#x2010;CoV&#x2010;2 infection and cardiovascular diseases: emphasis on mitochondrial dysfunction and immune&#x2010;inflammation. J Transl Med. 2023;21(1):915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10725609</ArticleId><ArticleId IdType="pubmed">38104081</ArticleId></ArticleIdList></Reference><Reference><Citation>Hon K, Leung A, Leung K, Wong A. Impact of &#x201c;long covid&#x201d; on children: global and Hong Kong perspectives. Curr Pediatr Rev. 2024;20(1):59&#x2010;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">36281870</ArticleId></ArticleIdList></Reference><Reference><Citation>Yisimayi A, Song W, Wang J, et&#xa0;al. Repeated Omicron exposures override ancestral SARS&#x2010;CoV&#x2010;2 immune imprinting. Nature. 2024;625(7993):148&#x2010;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10764275</ArticleId><ArticleId IdType="pubmed">37993710</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulliford MC, Steves CJ. Access to COVID&#x2010;19 vaccination and COVID&#x2010;19&#x2010;related hospital admissions and mortality. Lancet. 2024. S0140&#x2010;6736(23)02622&#x2010;02623.</Citation><ArticleIdList><ArticleId IdType="pubmed">38237626</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, et&#xa0;al. Prevalence of post&#x2010;acute COVID&#x2010;19 syndrome symptoms at different follow&#x2010;up periods: a systematic review and meta&#x2010;analysis. Clin Microbiol Infect. 2022;28(5):657&#x2010;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi BY, Grace AR, Tsai J. Heterogeneity of COVID&#x2010;19 symptoms and associated factors: longitudinal analysis of laboratory&#x2010;confirmed COVID&#x2010;19 cases in San Antonio. PLoS One. 2023;18(12):e0295418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10707584</ArticleId><ArticleId IdType="pubmed">38064447</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Cancela&#x2010;Cilleruelo I, Moro&#x2010;L&#xf3;pez&#x2010;Menchero P, et&#xa0;al. Exploring the trajectory curve of long&#x2010;term musculoskeletal post&#x2010;COVID pain symptoms in hospitalized COVID&#x2010;19 survivors: a multicenter study. Pain. 2023;164(2):413&#x2010;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">35930390</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Torres&#x2010;Macho J, Guijarro C, Mart&#xed;n&#x2010;Guerrero JD, Pellicer&#x2010;Valero OJ, Plaza&#x2010;Manzano G. Trajectory of gastrointestinal symptoms in previously hospitalized COVID&#x2010;19 survivors: the long COVID experience multicenter study. Viruses. 2023;15(5):1134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10221203</ArticleId><ArticleId IdType="pubmed">37243220</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et&#xa0;al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2023;401(10393):e21&#x2010;e33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, et&#xa0;al. True prevalence of long&#x2010;COVID in a nationwide, population cohort study. Nat Commun. 2023;14(1):7892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10689486</ArticleId><ArticleId IdType="pubmed">38036541</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2010;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Chen L, Wang P, et&#xa0;al. Neurological complications during the Omicron COVID&#x2010;19 wave in China: a cohort study. Eur J Neurol. 2024;31(1):e16096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11235988</ArticleId><ArticleId IdType="pubmed">37877685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemir H, B&#xfc;lb&#xfc;l GA, Kirti&#x15f; E, G&#xfc;ney S, Sanhal CY, Mendilcio&#x11f;lu &#x130;&#x130;. Evaluation of long&#x2010;COVID symptoms in women infected with SARS&#x2010;CoV&#x2010;2 during pregnancy. Int J Gynaecol Obstet. 2024;164(1):148&#x2010;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">37387323</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison CJ, Davies B, Cooper E, et&#xa0;al. Long&#x2010;term health impacts of COVID&#x2010;19 among 242,712 adults in England. Nat Commun. 2023;14(1):6588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10598213</ArticleId><ArticleId IdType="pubmed">37875536</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, et&#xa0;al. Physical and mental health 3 months after SARS&#x2010;CoV&#x2010;2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6(4):230&#x2010;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertollo AG, Leite Galvan AC, Dama Mingoti ME, Dallagnol C, Ign&#xe1;cio ZM. Impact of COVID&#x2010;19 on anxiety and depression&#x2014;biopsychosocial factors. CNS Neurol Disord Drug Targets. 2024;23(1):122&#x2010;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">36809942</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et&#xa0;al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27(4):601&#x2010;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui L, et&#xa0;al. Fatigue and cognitive impairment in post&#x2010;COVID&#x2010;19 syndrome: a systematic review and meta&#x2010;analysis. Brain Behav Immun. 2022;101:93&#x2010;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N, Peli E, Calza S, et&#xa0;al. Physical, cognitive and mental health outcomes in 1&#x2010;year survivors of COVID&#x2010;19&#x2010;associated ARDS. Thorax. 2022;77(3):300&#x2010;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">34588274</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro&#x2010;Almagro F, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2010;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, et&#xa0;al. Dysregulation of brain and choroid plexus cell types in severe COVID&#x2010;19. Nature. 2021;595(7868):565&#x2010;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso&#x2010;Lana S, Marqui&#xe9; M, Ruiz A, Boada M. Cognitive and neuropsychiatric manifestations of COVID&#x2010;19 and effects on elderly individuals with dementia. Front Aging Neurosci. 2020;12:588872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7649130</ArticleId><ArticleId IdType="pubmed">33192483</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Li W, Lukiw W. Ubiquity of the SARS&#x2010;CoV&#x2010;2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain. Folia Neuropathol. 2021;59(3):232&#x2010;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">34628788</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez&#x2010;Rodr&#xed;guez P, D&#xed;az de Bustamante M, Aparicio Moll&#xe1; S, et&#xa0;al. Functional, cognitive, and nutritional decline in 435 elderly nursing home residents after the first wave of the COVID&#x2010;19 pandemic. Eur Geriatr Med. 2021;12(6):1137&#x2010;1145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222945</ArticleId><ArticleId IdType="pubmed">34165775</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Liu Q, Zhang J, Xu S. COVID&#x2010;19 and trained immunity: the inflammatory burden of long covid. Front Immunol. 2023;14:1294959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10713746</ArticleId><ArticleId IdType="pubmed">38090572</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y, Mo C, Xu S, et&#xa0;al. Research progress on perioperative blood&#x2010;brain barrier damage and its potential mechanism. Front Cell Dev Biol. 2023;11:1174043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10124715</ArticleId><ArticleId IdType="pubmed">37101615</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld CS, Wang L. Prevalence of olfactory dysfunction with the omicron variant of SARS&#x2010;CoV&#x2010;2: a systematic review and meta&#x2010;analysis. Cells. 2023;12(3):430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9913864</ArticleId><ArticleId IdType="pubmed">36766771</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Liang J, Chen D, et&#xa0;al. Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection. Brain Behav Immun. 2024;115:209&#x2010;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">37858739</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Streit S, Dittmayer C, Manitius RV, Radbruch H, Heppner FL. The neurobiology of SARS&#x2010;CoV&#x2010;2 infection. Nat Rev Neurosci. 2024;25(1):30&#x2010;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">38049610</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al&#x2010;Aly Z. Long&#x2010;term neurologic outcomes of COVID&#x2010;19. Nat Med. 2022;28(11):2406&#x2010;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dondaine T, Ruthmann F, Vuotto F, et&#xa0;al. Long&#x2010;term cognitive impairments following COVID&#x2010;19: a possible impact of hypoxia. J Neurol. 2022;269(8):3982&#x2010;3989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8944178</ArticleId><ArticleId IdType="pubmed">35325308</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahani M, Dokaneheifard S, Mansouri K. Hypoxia: a key feature of COVID&#x2010;19 launching activation of HIF&#x2010;1 and cytokine storm. J Inflamm (Lond). 2020;17:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594974</ArticleId><ArticleId IdType="pubmed">33139969</ArticleId></ArticleIdList></Reference><Reference><Citation>Serebrovska ZO, Chong EY, Serebrovska TV, Tumanovska LV, Hypoxia XiL. HIF&#x2010;1&#x3b1;, and COVID&#x2010;19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin. 2020;41(12):1539&#x2010;1546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588589</ArticleId><ArticleId IdType="pubmed">33110240</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung AL, Vanderheiden A, Nordvig AS, et&#xa0;al. COVID&#x2010;19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. 2022;145(12):4193&#x2010;4201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;Casta&#xf1;eda A, Lu P, Geraghty AC, et&#xa0;al. Mild respiratory COVID can cause multi&#x2010;lineage neural cell and myelin dysregulation. Cell. 2022;185(14):2452&#x2010;2468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484&#x2010;3496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes&#x2010;Dantas FL, Fernandes GG, Gutman EG, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 Spike protein induces TLR4&#x2010;mediated long&#x2010;term cognitive dysfunction recapitulating post&#x2010;COVID&#x2010;19 syndrome in mice. Cell Rep. 2023;42(3):112189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long COVID&#x2010;19. N Engl J Med. 2022;387(19):1813&#x2010;1815.</Citation><ArticleIdList><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Wang W, Chen Z, et&#xa0;al. A vaccine targeting the RBD of the S protein of SARS&#x2010;CoV&#x2010;2 induces protective immunity. Nature. 2020;586(7830):572&#x2010;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">32726802</ArticleId></ArticleIdList></Reference><Reference><Citation>He C, Yang J, Hong W, et&#xa0;al. A self&#x2010;assembled trimeric protein vaccine induces protective immunity against Omicron variant. Nat Commun. 2022;13(1):5459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9482656</ArticleId><ArticleId IdType="pubmed">36115859</ArticleId></ArticleIdList></Reference><Reference><Citation>Regev&#x2010;Yochay G, Gonen T, Gilboa M, et&#xa0;al. Efficacy of a fourth dose of COVID&#x2010;19 mRNA vaccine against omicron. N Engl J Med. 2022;386(14):1377&#x2010;1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006792</ArticleId><ArticleId IdType="pubmed">35297591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang Y, Huang B, et&#xa0;al. Development of an inactivated vaccine candidate, BBIBP&#x2010;CorV, with potent protection against SARS&#x2010;CoV&#x2010;2. Cell. 2020;182(3):713&#x2010;721. e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275151</ArticleId><ArticleId IdType="pubmed">32778225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani OT, Hitchings M, Dorion M, et&#xa0;al. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated pandemic of covid&#x2010;19 in Brazil: test negative case&#x2010;control study. BMJ. 2021;374:n2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377801</ArticleId><ArticleId IdType="pubmed">34417194</ArticleId></ArticleIdList></Reference><Reference><Citation>Voysey M, Clemens S, Madhi SA, et&#xa0;al. Safety and efficacy of the ChAdOx1 nCoV&#x2010;19 vaccine (AZD1222) against SARS&#x2010;CoV&#x2010;2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99&#x2010;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723445</ArticleId><ArticleId IdType="pubmed">33306989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadoff J, Gray G, Vandebosch A, et&#xa0;al. Safety and efficacy of single&#x2010;dose Ad26.COV2.S vaccine against Covid&#x2010;19. N Engl J Med. 2021;384(23):2187&#x2010;2201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220996</ArticleId><ArticleId IdType="pubmed">33882225</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Yang W, Chen F, Cui L. COVID&#x2010;19 and cognitive impairment: neuroinvasive and blood&#x2012;brain barrier dysfunction. J Neuroinflammation. 2022;19(1):222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9450840</ArticleId><ArticleId IdType="pubmed">36071466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiew CJ, Premikha M, Chong CY, et&#xa0;al. Effectiveness of primary series and booster vaccination against SARS&#x2010;CoV&#x2010;2 infection and hospitalisation among adolescents aged 12&#x2013;17 years in Singapore: a national cohort study. Lancet Infect Dis. 2023;23(2):177&#x2010;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9519171</ArticleId><ArticleId IdType="pubmed">36182678</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsenault C, Lewis TP, Kapoor NR, et&#xa0;al. Health system quality and COVID&#x2010;19 vaccination: a cross&#x2010;sectional analysis in 14 countries. Lancet Glob Health. 2024;12(1):e156&#x2010;e165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10716622</ArticleId><ArticleId IdType="pubmed">38096888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus JV, Wyka K, White TM, et&#xa0;al. A survey of COVID&#x2010;19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;29(2):366&#x2010;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">36624316</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo&#x2010;Castineira E, Rawlik K, Bretherick AD, et&#xa0;al. GWAS and meta&#x2010;analysis identifies 49 genetic variants underlying critical COVID&#x2010;19. Nature. 2023;617(7962):764&#x2010;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10208981</ArticleId><ArticleId IdType="pubmed">37198478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Narayan RK, Prasoon P, et&#xa0;al. COVID&#x2010;19 vaccination may enhance hippocampal neurogenesis in adults. Brain Behav Immun. 2023;107:87&#x2010;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9527215</ArticleId><ArticleId IdType="pubmed">36202167</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly M, Robinson E. Depression and anxiety during COVID&#x2010;19. Lancet. 2022;399(10324):518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813060</ArticleId><ArticleId IdType="pubmed">35123689</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung CF, Pang D, Kam KQ, et&#xa0;al. BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population&#x2010;based cohort study. Lancet Child Adolesc Health. 2023;7(7):463&#x2010;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10185330</ArticleId><ArticleId IdType="pubmed">37201540</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasmin F, Najeeb H, Naeem U, et&#xa0;al. Adverse events following COVID&#x2010;19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023;11(3):e807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10022421</ArticleId><ArticleId IdType="pubmed">36988252</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamm TA, Partheym&#xfc;ller J, Mosor E, et&#xa0;al. Determinants of COVID&#x2010;19 vaccine fatigue. Nat Med. 2023;29(5):1164&#x2010;1171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10202806</ArticleId><ArticleId IdType="pubmed">36973410</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. Updated COVID&#x2010;19 vaccine now available in US, recommended for everyone older than 6 months. JAMA. 2023;330(15):1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">37721745</ArticleId></ArticleIdList></Reference><Reference><Citation>Simadibrata DM, Lesmana E, Gunawan J, Quigley EM, Simadibrata M. A systematic review of gut microbiota profile in COVID&#x2010;19 patients and among those who have recovered from COVID&#x2010;19. J Dig Dis. 2023;24(4):244&#x2010;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">37265376</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Pang X, Wu J, Liu T, Wang B, Cao H. Gut microbiota in COVID&#x2010;19: new insights from inside. Gut Microbes. 2023;15(1):2201157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10120564</ArticleId><ArticleId IdType="pubmed">37078497</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez&#x2010;Santacruz C, Tyrkalska SD, Candel S. The microbiota in long COVID. Int J Mol Sci. 2024;25(2):1330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10816132</ArticleId><ArticleId IdType="pubmed">38279329</ArticleId></ArticleIdList></Reference><Reference><Citation>Saviano A, Brigida M, Petruzziello C, et&#xa0;al. Intestinal damage, inflammation and microbiota alteration during COVID&#x2010;19 infection. Biomedicines. 2023;11(4):1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10135602</ArticleId><ArticleId IdType="pubmed">37189632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Lau RI, Liu Q, Su Q, Chan F, Ng SC. Gut microbiota in COVID&#x2010;19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol. 2023;20(5):323&#x2010;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9589856</ArticleId><ArticleId IdType="pubmed">36271144</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E, Qu R, Junqueira C, et&#xa0;al. Inflammasome activation in infected macrophages drives COVID&#x2010;19 pathology. Nature. 2022;606(7914):585&#x2010;593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9288243</ArticleId><ArticleId IdType="pubmed">35483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Synodinou KD, Nikolaki MD, Triantafyllou K, Kasti AN. Immunomodulatory effects of probiotics on COVID&#x2010;19 infection by targeting the gut&#x2010;lung axis microbial cross&#x2010;talk. Microorganisms. 2022;10(9):1764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9505869</ArticleId><ArticleId IdType="pubmed">36144365</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Jing Q, Li J, et&#xa0;al. Assessment of microbiota in the gut and upper respiratory tract associated with SARS&#x2010;CoV&#x2010;2 infection. Microbiome. 2023;11(1):38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9982190</ArticleId><ArticleId IdType="pubmed">36869345</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Weng S, Xia C, et&#xa0;al. Gastrointestinal symptoms of long COVID&#x2010;19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites. BMC Med. 2023;21(1):264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10355065</ArticleId><ArticleId IdType="pubmed">37468867</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancabelli L, Taurino G, Ticinesi A, et&#xa0;al. Disentangling the interactions between nasopharyngeal and gut microbiome and their involvement in the modulation of COVID&#x2010;19 infection. Microbiol Spectr. 2023;11(5):e0219423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10581039</ArticleId><ArticleId IdType="pubmed">37728335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose T, Wasimuddin, Acharya V, et&#xa0;al. A cross&#x2010;sectional study on the nasopharyngeal microbiota of individuals with SARS&#x2010;CoV&#x2010;2 infection across three COVID&#x2010;19 waves in India. Front Microbiol. 2023;14:1238829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10511876</ArticleId><ArticleId IdType="pubmed">37744900</ArticleId></ArticleIdList></Reference><Reference><Citation>Candel S, Tyrkalska SD, &#xc1;lvarez&#x2010;Santacruz C, Mulero V. The nasopharyngeal microbiome in COVID&#x2010;19. Emerg Microbes Infect. 2023;12(1):e2165970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9869994</ArticleId><ArticleId IdType="pubmed">36606725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sencio V, Machelart A, Robil C, et&#xa0;al. Alteration of the gut microbiota following SARS&#x2010;CoV&#x2010;2 infection correlates with disease severity in hamsters. Gut Microbes. 2022;14(1):2018900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8726722</ArticleId><ArticleId IdType="pubmed">34965194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, Wu J, Zeng Y, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 triggered oxidative stress and abnormal energy metabolism in gut microbiota. MedComm. 2022;3(1):e112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906553</ArticleId><ArticleId IdType="pubmed">35281785</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Zhao Y, Feng X, Xu H. SARS&#x2010;CoV&#x2010;2 infection threatening intestinal health: a review of potential mechanisms and treatment strategies. Crit Rev Food Sci Nutr. 2023;63(33):12578&#x2010;12596.</Citation><ArticleIdList><ArticleId IdType="pubmed">35894645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tursi A, Papa A. Intestinal microbiome modulation during coronavirus disease 2019: another chance to manage the disease. Gastroenterology. 2022;162(7):2134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492138</ArticleId><ArticleId IdType="pubmed">32946905</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wan Y, Zuo T, et&#xa0;al. Prolonged impairment of short&#x2010;chain fatty acid and l&#x2010;isoleucine biosynthesis in gut microbiome in patients with COVID&#x2010;19. Gastroenterology. 2022;162(2):548&#x2010;561. e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Zhu G, Lei X, et&#xa0;al. Genetic support of the causal association between gut microbiome and COVID&#x2010;19: a bidirectional Mendelian randomization study. Front Immunol. 2023;14:1217615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10360131</ArticleId><ArticleId IdType="pubmed">37483615</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Moriyama M, Ishii C, et&#xa0;al. High body temperature increases gut microbiota&#x2010;dependent host resistance to influenza A virus and SARS&#x2010;CoV&#x2010;2 infection. Nat Commun. 2023;14(1):3863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10313692</ArticleId><ArticleId IdType="pubmed">37391427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xf8;seid M, Holter JC, Holm K, et&#xa0;al. Gut microbiota composition during hospitalization is associated with 60&#x2010;day mortality after severe COVID&#x2010;19. Crit Care. 2023;27(1):69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9946863</ArticleId><ArticleId IdType="pubmed">36814280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannan A, Hoque MN, Noyon SH, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 infection alters the gut microbiome in diabetes patients: a cross&#x2010;sectional study from Bangladesh. J Med Virol. 2023;95(4):e28691.</Citation><ArticleIdList><ArticleId IdType="pubmed">36946508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng HY, Leung WK, Cheung KS. Association between gut microbiota and SARS&#x2010;CoV&#x2010;2 infection and vaccine immunogenicity. Microorganisms. 2023;11(2):452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9961186</ArticleId><ArticleId IdType="pubmed">36838417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes de Almeida V, Engel DF, Ricci MF, et&#xa0;al. Gut microbiota from patients with COVID&#x2010;19 cause alterations in mice that resemble post&#x2010;COVID symptoms. Gut Microbes. 2023;15(2):2249146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10481883</ArticleId><ArticleId IdType="pubmed">37668317</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C, Viduto V, Fabrowski M, et&#xa0;al. The importance of the gut microbiome in the pathogenesis and transmission of SARS&#x2010;CoV&#x2010;2. Gut Microbes. 2023;15(1):2244718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10416738</ArticleId><ArticleId IdType="pubmed">37559387</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Ghosh TS, McCann R, et&#xa0;al. Robust cross&#x2010;cohort gut microbiome associations with COVID&#x2010;19 severity. Gut Microbes. 2023;15(1):2242615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10411309</ArticleId><ArticleId IdType="pubmed">37550964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancona G, Alagna L, Alteri C, et&#xa0;al. Gut and airway microbiota dysbiosis and their role in COVID&#x2010;19 and long&#x2010;COVID. Front Immunol. 2023;14:1080043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10030519</ArticleId><ArticleId IdType="pubmed">36969243</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno&#x2010;Corona NC, L&#xf3;pez&#x2010;Ortega O, P&#xe9;rez&#x2010;Mart&#xed;nez CA, et&#xa0;al. Dynamics of the microbiota and its relationship with post&#x2010;COVID&#x2010;19 syndrome. Int J Mol Sci. 2023;24(19):14822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10573029</ArticleId><ArticleId IdType="pubmed">37834270</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang H, Liu QP. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential. World J Gastroenterol. 2022;28(47):6689&#x2010;6701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9813939</ArticleId><ArticleId IdType="pubmed">36620345</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Deng J, Li J, et&#xa0;al. Changes of gut microbiota under different nutritional methods in elderly patients with severe COVID&#x2010;19 and their relationship with prognosis. Front Immunol. 2023;14:1260112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10533997</ArticleId><ArticleId IdType="pubmed">37781374</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong H, Kim JH, Han YH, et&#xa0;al. Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis. Front Immunol. 2023;14:1079277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083496</ArticleId><ArticleId IdType="pubmed">37051240</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, Takeuchi T, Masuoka H, et&#xa0;al. Human gut microbiota and its metabolites impact immune responses in COVID&#x2010;19 and its complications. Gastroenterology. 2023;164(2):272&#x2010;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499989</ArticleId><ArticleId IdType="pubmed">36155191</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Wu Y, Yin X, Ma H, Zhang J. The causal links between gut microbiota and COVID&#x2010;19: a Mendelian randomization study. J Med Virol. 2023;95(5):e28784.</Citation><ArticleIdList><ArticleId IdType="pubmed">37219044</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleftheriotis G, Tsounis EP, Aggeletopoulou I, et&#xa0;al. Alterations in gut immunological barrier in SARS&#x2010;CoV&#x2010;2 infection and their prognostic potential. Front Immunol. 2023;14:1129190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10050566</ArticleId><ArticleId IdType="pubmed">37006316</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang W, Zhang S, Qian H, et&#xa0;al. Association of gut microbiota with COVID&#x2010;19 susceptibility and severity: a two&#x2010;sample Mendelian randomization study. J Med Virol. 2023;95(4):e28734.</Citation><ArticleIdList><ArticleId IdType="pubmed">37185856</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Ye B, Su W, et&#xa0;al. The causal role of gut microbiota in susceptibility and severity of COVID&#x2010;19: a bidirectional Mendelian randomization study. J Med Virol. 2023;95(7):e28880.</Citation><ArticleIdList><ArticleId IdType="pubmed">37409643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Zhang Y, Li C, Chang W, Zhang L. The relationship between gut microbiota and COVID&#x2010;19 progression: new insights into immunopathogenesis and treatment. Front Immunol. 2023;14:1180336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10185909</ArticleId><ArticleId IdType="pubmed">37205106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n Gim&#xe9;nez VM, Modrego J, G&#xf3;mez&#x2010;Garre D, Manucha W, de Las Heras N. Gut microbiota dysbiosis in COVID&#x2010;19: modulation and approaches for prevention and therapy. Int J Mol Sci. 2023;24(15):12249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10419057</ArticleId><ArticleId IdType="pubmed">37569625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang IC, Vasquez R, Song JH, Engstrand L, Valeriano VD, Kang DK. Alterations in the gut microbiome and its metabolites are associated with the immune response to mucosal immunization with Lactiplantibacillus plantarum&#x2010;displaying recombinant SARS&#x2010;CoV&#x2010;2 spike epitopes in mice. Front Cell Infect Microbiol. 2023;13:1242681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10495993</ArticleId><ArticleId IdType="pubmed">37705931</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Wang N, Fan C, et&#xa0;al. Disturbance of adaptive immunity system was accompanied by a decrease in plasma short&#x2010;chain fatty acid for patients hospitalized during SARS&#x2010;CoV&#x2010;2 infection after COVID&#x2010;19 vaccination. J Inflamm Res. 2023;16:5261&#x2010;5272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10656857</ArticleId><ArticleId IdType="pubmed">38026252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi Badi S, Tarashi S, Fateh A, Rohani P, Masotti A, Siadat SD. From the role of microbiota in gut&#x2010;lung axis to SARS&#x2010;CoV&#x2010;2 pathogenesis. Mediators Inflamm. 2021;2021:6611222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8059477</ArticleId><ArticleId IdType="pubmed">33953641</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer AM, Matos YL, Lin HC, et&#xa0;al. Gut&#x2010;brain pathogenesis of post&#x2010;acute COVID&#x2010;19 neurocognitive symptoms. Front Neurosci. 2023;17:1232480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10568482</ArticleId><ArticleId IdType="pubmed">37841680</ArticleId></ArticleIdList></Reference><Reference><Citation>Malan&#x2010;M&#xfc;ller S, Valles&#x2010;Colomer M, Palomo T, Leza JC. The gut&#x2010;microbiota&#x2010;brain axis in a Spanish population in the aftermath of the COVID&#x2010;19 pandemic: microbiota composition linked to anxiety, trauma, and depression profiles. Gut Microbes. 2023;15(1):2162306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9851210</ArticleId><ArticleId IdType="pubmed">36651663</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong RG, Li J, Cheng J, et&#xa0;al. The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components. Nutrients. 2023;15(14):3258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10384867</ArticleId><ArticleId IdType="pubmed">37513676</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Guo Z, Wang Y, et&#xa0;al. Single&#x2010;nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID&#x2010;19 and Alzheimer's disease. Front Immunol. 2022;13:967356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538863</ArticleId><ArticleId IdType="pubmed">36211330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Xu J, Hou Y, et&#xa0;al. Network medicine links SARS&#x2010;CoV&#x2010;2/COVID&#x2010;19 infection to brain microvascular injury and neuroinflammation in dementia&#x2010;like cognitive impairment. Alzheimers Res Ther. 2021;13(1):110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189279</ArticleId><ArticleId IdType="pubmed">34108016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay ME, Madore C, Bordeleau M, Tian L, Verkhratsky A. Neuropathobiology of COVID&#x2010;19: the role for glia. Front Cell Neurosci. 2020;14:592214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693550</ArticleId><ArticleId IdType="pubmed">33304243</ArticleId></ArticleIdList></Reference><Reference><Citation>Samudyata, Oliveira AO, Malwade S, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 promotes microglial synapse elimination in human brain organoids. Mol Psychiatry. 2022;27(10):3939&#x2010;3950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9533278</ArticleId><ArticleId IdType="pubmed">36198765</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni TE, Medici V, Moretti M, et&#xa0;al. COVID&#x2010;19&#x2010;related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol. 2021;31(5):e12997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412067</ArticleId><ArticleId IdType="pubmed">34145669</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et&#xa0;al. Neuropathology of patients with COVID&#x2010;19 in Germany: a post&#x2010;mortem case series. Lancet Neurol. 2020;19(11):919&#x2010;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos H, Magira E, Bitzogli K, et&#xa0;al. Anti&#x2010;SARS&#x2010;CoV&#x2010;2 antibodies in the CSF, blood&#x2010;brain barrier dysfunction, and neurological outcome: studies in 8 stuporous and comatose patients. Neurol Neuroimmunol Neuroinflamm. 2020;7(6):e893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577546</ArticleId><ArticleId IdType="pubmed">32978291</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Ferse C, Kreye J, et&#xa0;al. High frequency of cerebrospinal fluid autoantibodies in COVID&#x2010;19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415&#x2010;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Boesl F, Goereci Y, et&#xa0;al. Association of cerebrospinal fluid brain&#x2010;binding autoantibodies with cognitive impairment in post&#x2010;COVID&#x2010;19 syndrome. Brain Behav Immun. 2023;109:139&#x2010;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Geanes ES, LeMaster C, Fraley ER, et&#xa0;al. Cross&#x2010;reactive antibodies elicited to conserved epitopes on SARS&#x2010;CoV&#x2010;2 spike protein after infection and vaccination. Sci Rep. 2022;12(1):6496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9019795</ArticleId><ArticleId IdType="pubmed">35444221</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasmi A, Kumar Mujawdiya P, Noor S, Piscopo S, R&#xe9;simont S, Menzel A. Increasing efficacy of covid&#x2010;19 vaccines by lifestyle interventions. Arch Razi Inst. 2022;77(5):1527&#x2010;1538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10133642</ArticleId><ArticleId IdType="pubmed">37123146</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani A, Sergi D, Zauli E, et&#xa0;al. Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS&#x2010;CoV&#x2010;2 infection. Front Nutr. 2023;10:1152254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10267353</ArticleId><ArticleId IdType="pubmed">37324739</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Dong Y, Jiao J, Wang P, Chen M, Li J. BBIBP&#x2010;CorV vaccination against the SARS&#x2010;CoV&#x2010;2 virus affects the gut microbiome. Vaccines (Basel). 2023;11(5):942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10223200</ArticleId><ArticleId IdType="pubmed">37243047</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Lok K, Sin ZY, et&#xa0;al. COVID&#x2010;19 mRNA vaccine&#x2010;mediated antibodies in human breast milk and their association with breast milk microbiota composition. NPJ Vaccines. 2023;8(1):151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10556030</ArticleId><ArticleId IdType="pubmed">37798293</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung J. Interaction between gut microbiota and COVID&#x2010;19 and its vaccines. World J Gastroenterol. 2022;28(40):5801&#x2010;5806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639653</ArticleId><ArticleId IdType="pubmed">36353201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong M, Lan T, Li Q, et&#xa0;al. A comprehensive perspective on the interaction between gut microbiota and COVID&#x2010;19 vaccines. Gut Microbes. 2023;15(1):2233146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337507</ArticleId><ArticleId IdType="pubmed">37431857</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M, Huang Y, Gui H, et&#xa0;al. Dynamic changes in host immune system and gut microbiota are associated with the production of SARS&#x2010;CoV&#x2010;2 antibodies. Gut. 2023;72(10):1996&#x2010;1999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10511961</ArticleId><ArticleId IdType="pubmed">36207022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B, Tang L, He W, et&#xa0;al. Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP&#x2010;CorV vaccine. Cell Rep Med. 2022;3(10):100752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9589008</ArticleId><ArticleId IdType="pubmed">36228621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SC, Peng Y, Zhang L, et&#xa0;al. Gut microbiota composition is associated with SARS&#x2010;CoV&#x2010;2 vaccine immunogenicity and adverse events. Gut. 2022;71(6):1106&#x2010;1116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8844967</ArticleId><ArticleId IdType="pubmed">35140064</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang G, Mao Y, Zhang W, et&#xa0;al. Explore the changes of intestinal flora in patients with coronavirus disease 2019 based on bioinformatics. Front Cell Infect Microbiol. 2023;13:1265028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10611479</ArticleId><ArticleId IdType="pubmed">37900316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ale EC, Binetti AG. Role of probiotics, prebiotics, and synbiotics in the elderly: insights into their applications. Front Microbiol. 2021;12:631254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876055</ArticleId><ArticleId IdType="pubmed">33584631</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaezi M, Ravanshad S, Akbari Rad M, Zarrinfar H, Kabiri M. The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID&#x2010;19 patients: a randomized placebo&#x2010;controlled trial. J Med Virol. 2023;95(2):e28463.</Citation><ArticleIdList><ArticleId IdType="pubmed">36602047</ArticleId></ArticleIdList></Reference><Reference><Citation>Reino&#x2010;Gelardo S, Palop&#x2010;Cervera M, Aparisi&#x2010;Valero N, et&#xa0;al. Effect of an immune&#x2010;boosting, antioxidant and anti&#x2010;inflammatory food supplement in hospitalized COVID&#x2010;19 patients: a prospective randomized pilot study. Nutrients. 2023;15(7):1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10096722</ArticleId><ArticleId IdType="pubmed">37049576</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsg&#xe5;rd RA, Rode J, Lobenius&#x2010;Palm&#xe9;r K, et&#xa0;al. Limosilactobacillus reuteri DSM 17938 supplementation and SARS&#x2010;CoV&#x2010;2 specific antibody response in healthy adults: a randomized, triple&#x2010;blinded, placebo&#x2010;controlled trial. Gut Microbes. 2023;15(1):2229938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10321188</ArticleId><ArticleId IdType="pubmed">37401761</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez&#x2010;Castrell&#xf3;n P, Gandara&#x2010;Mart&#xed; T, Abreu Y, Abreu AT, et&#xa0;al. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple&#x2010;blinded, placebo&#x2010;controlled trial. Gut Microbes. 2022;14(1):2018899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757475</ArticleId><ArticleId IdType="pubmed">35014600</ArticleId></ArticleIdList></Reference><Reference><Citation>Saviano A, Potenza A, Siciliano V, et&#xa0;al. COVID&#x2010;19 pneumonia and gut inflammation: the role of a mix of three probiotic strains in reducing inflammatory markers and need for oxygen support. J Clin Med. 2022;11(13):3758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9267834</ArticleId><ArticleId IdType="pubmed">35807040</ArticleId></ArticleIdList></Reference><Reference><Citation>De Boeck I, Cauwenberghs E, Spacova I, et&#xa0;al. Randomized, double&#x2010;blind, placebo&#x2010;controlled trial of a throat spray with selected Lactobacilli in COVID&#x2010;19 outpatients. Microbiol Spectr. 2022;10(5):e0168222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9604152</ArticleId><ArticleId IdType="pubmed">36154666</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pierro F, Iqtadar S, Mumtaz SU, et&#xa0;al. Clinical effects of Streptococcus salivarius K12 in hospitalized COVID&#x2010;19 patients: results of a preliminary study. Microorganisms. 2022;10(10):1926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9609702</ArticleId><ArticleId IdType="pubmed">36296202</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Desai AD, Wan EY. Post&#x2010;COVID&#x2010;19 condition. Annu Rev Med. 2023;74:55&#x2010;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Neumann C, Bahmer T, et&#xa0;al. Fatigue and cognitive impairment after COVID&#x2010;19: a prospective multicentre study. EClinicalMedicine. 2022;53:101651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9482331</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Wang YR, Wang QH, et&#xa0;al. Post&#x2010;infection cognitive impairments in a cohort of elderly patients with COVID&#x2010;19. Mol Neurodegener. 2021;16(1):48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, et&#xa0;al. One&#x2010;year trajectory of cognitive changes in older survivors of COVID&#x2010;19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79(5):509&#x2010;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier&#x2010;Santos D, Padilha M, Fabiano GA, et&#xa0;al. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID&#x2010;19: a bibliometric analysis and systematic review. Trends Food Sci Technol. 2022;120:174&#x2010;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8720301</ArticleId><ArticleId IdType="pubmed">35002079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Pitre T, Ching C, Zeraatkar D, Gruchy S. Safety and efficacy of probiotic supplements as adjunctive therapies in patients with COVID&#x2010;19: a systematic review and meta&#x2010;analysis. PLoS One. 2023;18(3):e0278356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10065254</ArticleId><ArticleId IdType="pubmed">37000812</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoni E, Baud D, Agri VD, Gibson GR, Reid G. Probiotics and COVID&#x2010;19. Lancet Gastroenterol Hepatol. 2020;5(8):720&#x2010;721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357984</ArticleId><ArticleId IdType="pubmed">32673603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CS, Cha L, Sim M, et&#xa0;al. Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community&#x2010;dwelling older adults: a randomized, double&#x2010;blind, placebo&#x2010;controlled, multicenter trial. J Gerontol A Biol Sci Med Sci. 2021;76(1):32&#x2010;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861012</ArticleId><ArticleId IdType="pubmed">32300799</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi A, Jadhav SB, Shah N. A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post&#x2010;COVID fatigue. Medicines (Basel). 2021;8(9):47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8472462</ArticleId><ArticleId IdType="pubmed">34564089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozota M, Castro I, G&#xf3;mez&#x2010;Torres N, et&#xa0;al. Administration of Ligilactobacillus salivarius MP101 in an elderly nursing home during the COVID&#x2010;19 pandemic: immunological and nutritional impact. Foods. 2021;10(9):2149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8470390</ArticleId><ArticleId IdType="pubmed">34574259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozota M, Castro I, G&#xf3;mez&#x2010;Torres N, et&#xa0;al. Administration of Ligilactobacillus salivarius CECT 30632 to elderly during the COVID&#x2010;19 pandemic: nasal and fecal metataxonomic analysis and fatty acid profiling. Front Microbiol. 2022;13:1052675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9800801</ArticleId><ArticleId IdType="pubmed">36590434</ArticleId></ArticleIdList></Reference><Reference><Citation>Catinean A, Sida A, Silvestru C, Balan GG. Ongoing treatment with a spore&#x2010;based probiotic containing five strains of bacillus improves outcomes of mild COVID&#x2010;19. Nutrients. 2023;15(3):488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9920365</ArticleId><ArticleId IdType="pubmed">36771194</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobile V, Puoci F. Effect of a multi&#x2010;strain probiotic supplementation to manage stress during the COVID&#x2010;19 pandemic: a randomized, double&#x2010;blind, placebo&#x2010;controlled, cross&#x2010;over clinical trial. Neuropsychobiology. 2023;82(2):61&#x2010;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843736</ArticleId><ArticleId IdType="pubmed">36634645</ArticleId></ArticleIdList></Reference><Reference><Citation>Neris Almeida Viana S, do Reis Santos Pereira T, de Carvalho Alves J, et&#xa0;al. Benefits of probiotic use on COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Crit Rev Food Sci Nutr. 2022:1&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">36178362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray M, Manjunath A, Halami PM. Effect of probiotics as an immune modulator for the management of COVID&#x2010;19. Arch Microbiol. 2023;205(5):182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10098245</ArticleId><ArticleId IdType="pubmed">37031431</ArticleId></ArticleIdList></Reference><Reference><Citation>Akram N, Saeed F, Afzaal M, et&#xa0;al. Gut microbiota and synbiotic foods: unveiling the relationship in COVID&#x2010;19 perspective. Food Sci Nutr. 2023;11(3):1166&#x2010;1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10002946</ArticleId><ArticleId IdType="pubmed">36911846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohail A, Cheema HA, Mithani MS, et&#xa0;al. Probiotics for the prevention and treatment of COVID&#x2010;19: a rapid systematic review and meta&#x2010;analysis. Front Nutr. 2023;10:1274122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10641770</ArticleId><ArticleId IdType="pubmed">37964926</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista KS, de Albuquerque JG, Vasconcelos M, et&#xa0;al. Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID&#x2010;19. Nutr Res Rev. 2023;36(2):181&#x2010;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8593414</ArticleId><ArticleId IdType="pubmed">34668465</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Ran H, Wen X, et&#xa0;al. Probiotics improve symptoms of patients with COVID&#x2010;19 through gut&#x2010;lung axis: a systematic review and meta&#x2010;analysis. Front Nutr. 2023;10:1179432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10239816</ArticleId><ArticleId IdType="pubmed">37284648</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxami G, Kerezoudi EN, Eliopoulos C, Arapoglou D, Kyriacou A. The gut&#x2010;organ axis within the human body: gut dysbiosis and the role of prebiotics. Life (Basel). 2023;13(10):2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10608660</ArticleId><ArticleId IdType="pubmed">37895405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wischmeyer PE, Tang H, Ren Y, et&#xa0;al. Efficacy of probiotic treatment as post&#x2010;exposure prophylaxis for COVID&#x2010;19: a double&#x2010;blind, placebo&#x2010;controlled randomized trial. Clin Nutr. 2024;43(1):259&#x2010;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">38103462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau HC, Ng SC, Yu J. Targeting the gut microbiota in coronavirus disease 2019: hype or hope. Gastroenterology. 2022;162(1):9&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425294</ArticleId><ArticleId IdType="pubmed">34508775</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenazy MF, Aljohar HI, Alruwaili AR, et&#xa0;al. Gut microbiota dynamics in relation to long&#x2010;COVID&#x2010;19 syndrome: role of probiotics to combat psychiatric complications. Metabolites. 2022;12(10):912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9611210</ArticleId><ArticleId IdType="pubmed">36295814</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardi A, Kamran A, Pourfarzi F, et&#xa0;al. Potential of macronutrients and probiotics to boost immunity in patients with SARS&#x2010;COV&#x2010;2: a narrative review. Front Nutr. 2023;10:1161894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10259402</ArticleId><ArticleId IdType="pubmed">37312883</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;nning G, Montelius C, Hillman M, Larsson N. Intake of Lactiplantibacillus plantarum HEAL9 improves cognition in moderately stressed subjects: a randomized controlled study. Nutrients. 2023;15(15):3466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10421450</ArticleId><ArticleId IdType="pubmed">37571403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Gao G, Kwok LY, Sun Z. Gut microbiome&#x2010;targeted therapies for Alzheimer's disease. Gut Microbes. 2023;15(2):2271613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10631445</ArticleId><ArticleId IdType="pubmed">37934614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CS, Jung S, Hwang GS, Shin DM. Gut microbiota indole&#x2010;3&#x2010;propionic acid mediates neuroprotective effect of probiotic consumption in healthy elderly: a randomized, double&#x2010;blind, placebo&#x2010;controlled, multicenter trial and in vitro study. Clin Nutr. 2023;42(6):1025&#x2010;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">37150125</ArticleId></ArticleIdList></Reference><Reference><Citation>Laterza L, Putignani L, Settanni CR, et&#xa0;al. Ecology and machine learning&#x2010;based classification models of gut microbiota and inflammatory markers may evaluate the effects of probiotic supplementation in patients recently recovered from COVID&#x2010;19. Int J Mol Sci. 2023;24(7):6623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10094838</ArticleId><ArticleId IdType="pubmed">37047594</ArticleId></ArticleIdList></Reference><Reference><Citation>Duindam HB, Kessels R, van den Borst B, Pickkers P, Abdo WF. Long&#x2010;term cognitive performance and its relation to anti&#x2010;inflammatory therapy in a cohort of survivors of severe COVID&#x2010;19. Brain Behav Immun Health. 2022;25:100513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9482799</ArticleId><ArticleId IdType="pubmed">36159208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartos A, Weinerova J, Diondet S, Vales K. Effect of human probiotics on memory, psychological and biological measures in elderly: a study protocol of bi&#x2010;center, double&#x2010;blind, randomized, placebo&#x2010;controlled clinical trial (CleverAge Biota). Front Aging Neurosci. 2022;14:996234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9686296</ArticleId><ArticleId IdType="pubmed">36437993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreiro AL, Choi J, Ryou J, et&#xa0;al. Gut microbiome composition may be an indicator of preclinical Alzheimer's disease. Sci Transl Med. 2023;15(700):eabo2984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10680783</ArticleId><ArticleId IdType="pubmed">37315112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiani L. Early microbiome changes in neurodegenerative disease. Nat Rev Neurol. 2023;19(8):458.</Citation><ArticleIdList><ArticleId IdType="pubmed">37402802</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves J, Borges TJ, de Souza A. Microbiota and the response to vaccines against respiratory virus. Front Immunol. 2022;13:889945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9122122</ArticleId><ArticleId IdType="pubmed">35603203</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunken GR, Golding L, Schick A, Majdoubi A, Lavoie PM, Vallance BA. Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS&#x2010;CoV&#x2010;2 mRNA vaccination. Gut. 2023;73(1):208&#x2010;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715502</ArticleId><ArticleId IdType="pubmed">36549875</ArticleId></ArticleIdList></Reference><Reference><Citation>Daddi L, Dorsett Y, Geng T, et&#xa0;al. Baseline gut microbiome signatures correlate with immunogenicity of SARS&#x2010;CoV&#x2010;2 mRNA vaccines. Int J Mol Sci. 2023;24(14):11703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10380288</ArticleId><ArticleId IdType="pubmed">37511464</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Zhang L, Mok C, et&#xa0;al. Baseline gut microbiota and metabolome predict durable immunogenicity to SARS&#x2010;CoV&#x2010;2 vaccines. Signal Transduct Target Ther. 2023;8(1):373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10518331</ArticleId><ArticleId IdType="pubmed">37743379</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JL, Mullish BH, Danckert NP, et&#xa0;al. The gut microbiota and metabolome are associated with diminished COVID&#x2010;19 vaccine&#x2010;induced antibody responses in immunosuppressed inflammatory bowel disease patients. EBioMedicine. 2023;88:104430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9831064</ArticleId><ArticleId IdType="pubmed">36634565</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancolella M, Colona VL, Luzzatto L, et&#xa0;al. COVID&#x2010;19 annual update: a narrative review. Hum Genomics. 2023;17(1):68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10367267</ArticleId><ArticleId IdType="pubmed">37488607</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S, Seo H. Dietary intervention with functional foods modulating gut microbiota for improving the efficacy of COVID&#x2010;19 vaccines. Heliyon. 2023;9(5):e15668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10121067</ArticleId><ArticleId IdType="pubmed">37124341</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang B, Wang J, Li L. Recent five&#x2010;year progress in the impact of gut microbiota on vaccination and possible mechanisms. Gut Pathog. 2023;15(1):27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10258485</ArticleId><ArticleId IdType="pubmed">37308966</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong H, Choi BK, Han YH, et&#xa0;al. Gut microbiota as a potential key to modulating humoral immunogenicity of new platform COVID&#x2010;19 vaccines. Signal Transduct Target Ther. 2023;8(1):178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154741</ArticleId><ArticleId IdType="pubmed">37137906</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan A, Carding SR, Hall LJ. The early&#x2010;life gut microbiome and vaccine efficacy. Lancet Microbe. 2022;3(10):e787&#x2010;e794.</Citation><ArticleIdList><ArticleId IdType="pubmed">36088916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Huang S, Liu X, et&#xa0;al. Safety and efficacy of the intranasal spray SARS&#x2010;CoV&#x2010;2 vaccine dNS1&#x2010;RBD: a multicentre, randomised, double&#x2010;blind, placebo&#x2010;controlled, phase 3 trial. Lancet Respir Med. 2023;11(12):1075&#x2010;1088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10682370</ArticleId><ArticleId IdType="pubmed">37979588</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasaewes K, Chaiwarith R, Chattipakorn N, Chattipakorn SC. Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS&#x2010;CoV&#x2010;2 infection. Life Sci. 2023;332:122136.</Citation><ArticleIdList><ArticleId IdType="pubmed">37783267</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#x12b;v&#x12b;ba M, Silami&#x137;ele L, Birzniece L, et&#xa0;al. Gut microbiome composition and dynamics in hospitalized COVID&#x2010;19 patients and patients with post&#x2010;acute COVID&#x2010;19 syndrome. Int J Mol Sci. 2024;25(1):567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10779053</ArticleId><ArticleId IdType="pubmed">38203738</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters V, van de Steeg E, van Bilsen J, Meijerink M. Mechanisms and immunomodulatory properties of pre&#x2010; and probiotics. Benef Microbes. 2019;10(3):225&#x2010;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">30827150</ArticleId></ArticleIdList></Reference><Reference><Citation>Handajani YS, Turana Y, Yogiara Y, et&#xa0;al. Effects of Tempeh probiotics on elderly with cognitive impairment. Front Aging Neurosci. 2022;14:891773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9263263</ArticleId><ArticleId IdType="pubmed">35813939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Wang K, Zhao W. Gut microbiota in perioperative neurocognitive disorders: current evidence and future directions. Front Immunol. 2023;14:1178691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10192759</ArticleId><ArticleId IdType="pubmed">37215136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Wu X, Liu B, Huang H, Zhou C, Liang P. The contribution of probiotics for the double&#x2010;edge effect of cefazolin on postoperative neurocognitive disorders by rebalancing the gut microbiota. Front Neurosci. 2023;17:1156453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10174111</ArticleId><ArticleId IdType="pubmed">37179548</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu D, Xue L, Li H, Du J. Probiotics modulate the microbiota&#x2010;gut&#x2010;brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B. 2020;10(3):475&#x2010;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7049608</ArticleId><ArticleId IdType="pubmed">32140393</ArticleId></ArticleIdList></Reference><Reference><Citation>Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H. Probiotics for Alzheimer's disease: a systematic review. Nutrients. 2021;14(1):20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8746506</ArticleId><ArticleId IdType="pubmed">35010895</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman P, Est&#xe9;vez AF, Miras A, et&#xa0;al. A pilot randomized controlled trial to explore cognitive and emotional effects of probiotics in fibromyalgia. Sci Rep. 2018;8(1):10965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053373</ArticleId><ArticleId IdType="pubmed">30026567</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdebenito&#x2010;Navarrete H, Fuentes&#x2010;Barrera V, Smith CT, et&#xa0;al. Can probiotics, particularly Limosilactobacillus fermentum UCO&#x2010;979C and Lacticaseibacillus rhamnosus UCO&#x2010;25A, be preventive alternatives against SARS&#x2010;CoV&#x2010;2. Biology (Basel). 2023;12(3):384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10045641</ArticleId><ArticleId IdType="pubmed">36979076</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S, Zhao Y, Zeng N, et&#xa0;al. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update. Mol Psychiatry. 2023;28(10):4056&#x2010;4069.</Citation><ArticleIdList><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomilio AB, Vitale AA, Lazarowski AJ. COVID&#x2010;19 and Alzheimer's disease: neuroinflammation, oxidative stress, ferroptosis, and mechanisms involved. Curr Med Chem. 2023;30(35):3993&#x2010;4031.</Citation><ArticleIdList><ArticleId IdType="pubmed">36200215</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta Pasini AM, Stranieri C, Girelli D, Busti F, Cominacini L. Is ferroptosis a key component of the process leading to multiorgan damage in COVID&#x2010;19. Antioxidants (Basel). 2021;10(11):1677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615234</ArticleId><ArticleId IdType="pubmed">34829548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Sun C, Chen X, et&#xa0;al. COVID&#x2010;19&#x2010;related brain injury: the potential role of ferroptosis. J Inflamm Res. 2022;15:2181&#x2010;2198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994634</ArticleId><ArticleId IdType="pubmed">35411172</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankauskas SS, Kansakar U, Sardu C, et&#xa0;al. COVID&#x2010;19 causes ferroptosis and oxidative stress in human endothelial cells. Antioxidants (Basel). 2023;12(2):326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9952002</ArticleId><ArticleId IdType="pubmed">36829885</ArticleId></ArticleIdList></Reference><Reference><Citation>Peleman C, Van Coillie S, Ligthart S, et&#xa0;al. Ferroptosis and pyroptosis signatures in critical COVID&#x2010;19 patients. Cell Death Differ. 2023;30(9):2066&#x2010;2077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10482958</ArticleId><ArticleId IdType="pubmed">37582864</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>